Phase
Condition
Hearing Loss
Treatment
Placebo
Pseudoephedrine Pill
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
New patient requiring HBOT (either inpatient or outpatient)
Age greater than or equal to 18 years and less than 80 years
Fluent in English
Full decision capacity
Able and medically cleared to swallow a pill
Exclusion
Exclusion Criteria:
Enrollment would delay hyperbaric therapy more than 30 minutes in patients withemergent indications (example: Central Retinal Arterial Occlusion, Carbon Monoxide,Air Gas Embolism)
Contraindication to pseudoephedrine (monoamine oxidase inhibitors (MAOI) use,pregnancy, glaucoma, heart disease, allergy to drug class)
Systolic Blood Pressure >160
Diastolic Blood Pressure > 90
Heart Rate >100
Decongestant/antihistamine/pseudoephedrine/nasal steroid/oxymetazoline use within 12hours.
Prisoner
Intubated
Unable to swallow oral medications
Study Design
Study Description
Connect with a study center
John Muir Health
Walnut Creek, California 94598
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.